![Health Ministry sets 31st December, 2024 as implementation date for Jan Vishwas Act amendments to Drugs and Cosmetics Act, 1940; drug manufacturers may be subject to increased fines for utilizing government analysts’ reports in advertisements](https://lexplosion.in/wp-content/uploads/2024/04/Health-Ministry-sets-31st-December-2024-as-implementation-date-for-Jan-Vishwas-Act-amend.jpg)
![Health Ministry sets 31st December, 2024 as implementation date for Jan Vishwas Act amendments to Drugs and Cosmetics Act, 1940; drug manufacturers may be subject to increased fines for utilizing government analysts’ reports in advertisements](https://lexplosion.in/wp-content/uploads/2024/04/Health-Ministry-sets-31st-December-2024-as-implementation-date-for-Jan-Vishwas-Act-amend.jpg)
![Health Ministry revises Drugs Rules 1945; permits tablet and capsule quantities exceeding 10 to be packaged in multiples of both 7 and 5](https://lexplosion.in/wp-content/uploads/2024/03/Health-Ministry-revises-Drugs-Rules-1945-permits-tablet-and-capsule-quantities-exceeding-10-to-be-packaged-in-multiples-of-both-7-and-5.jpg)
Health Ministry revises Drugs Rules 1945; permits tablet and capsule quantities exceeding 10 to be packaged in multiples of both 7 and 5
In furtherance to what we reported earlier (please refer to e-mails in trail), the Ministry of... Read More![CDSCO mandates online submission of Period Safety Update Reports (PSURs) through Sugam Portal, offline submissions to be discontinued from 11th March, 2024](https://lexplosion.in/wp-content/uploads/2024/02/CDSCO-mandates-online-submission-of-Period-Safety-Update-Reports-PSURs-through-Sugam-Portal-offline-submissions-to-be-discontinued-from-11th-March-2024.jpg)
CDSCO mandates online submission of Period Safety Update Reports (PSURs) through Sugam Portal, offline submissions to be discontinued from 11th March, 2024
With a view to streamline the regulatory submission procedure, the Central Drugs Standards Control... Read More![Dial Schedule M: India’s drug manufacturing practices to undergo major overhaul](https://lexplosion.in/wp-content/uploads/2024/02/Indias-drug-manufacturing-practices-to-undergo-major-overhaul.jpg)
Dial Schedule M: India’s drug manufacturing practices to undergo major overhaul
If you are a pharmaceutical company in India with a turnover of more than Rs. 250 crores, you only... Read More![Health Ministry permits the sale of Oseltamivir Phosphate and Zanamivir akin to Schedule H1 drugs, with restrictions on sale and export regulated by the Government and DCGI](https://lexplosion.in/wp-content/uploads/2024/02/6.jpg)
Health Ministry permits the sale of Oseltamivir Phosphate and Zanamivir akin to Schedule H1 drugs, with restrictions on sale and export regulated by the Government and DCGI
Ministry of Health and Family Welfare has issued a Notification dated February 5, 2024, revoking... Read More![Public comments invited on proposed amendments to First and Second Schedule of the Drugs and Cosmetics Act till 12th April, 2023](https://lexplosion.in/wp-content/uploads/2024/02/Public-comments-invited-on-proposed-amendments-to-First-and-Second-Schedule-of-the-Drugs-and-Cosmetics-Act-till-12th-April-2023.jpg)